JSA advised Unipath Specialty Laboratory Limited on the acquisition of equity share capital of Ravula Health Care Private Limited, an entity engaged in providing pathology, diagnostic, and imaging services. The transaction is structured in multi-independent tranches resulting in acquisition of 100% shares of Ravula Health Care Private Limited by Unipath Specialty Laboratory Limited. Unipath Specialty Laboratory Limited has successfully established itself as one of the leading diagnostic brands in Western India having successfully expanded across 11 states.
Our deal team comprised Partner, Rinku Ambekar and Principal Associate, Reshma Oak.
Rinku has a diverse corporate practice focused on cross-border M&A representing clients in the United States, Europe, Singapore, Malaysia, Japan, Australia, United Kingdom and her experience extends to takeovers, buyouts, private equity transactions, creation of joint ventures, strategic alliances, stock acquisitions, business acquisitions, asset acquisitions, restructurings, corporate governance, commercial and corporate agreements.